[go: up one dir, main page]

DK1336407T3 - Præparat indeholdende en angiotensin-II-receptorantagonist og et diuretikum og anvendelse deraf til behandling af hypertension - Google Patents

Præparat indeholdende en angiotensin-II-receptorantagonist og et diuretikum og anvendelse deraf til behandling af hypertension

Info

Publication number
DK1336407T3
DK1336407T3 DK01982846T DK01982846T DK1336407T3 DK 1336407 T3 DK1336407 T3 DK 1336407T3 DK 01982846 T DK01982846 T DK 01982846T DK 01982846 T DK01982846 T DK 01982846T DK 1336407 T3 DK1336407 T3 DK 1336407T3
Authority
DK
Denmark
Prior art keywords
angiotensin
receptor antagonist
hypertension
diuretic
treatment
Prior art date
Application number
DK01982846T
Other languages
English (en)
Inventor
Toshio Sada
Makoto Mizuno
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26604360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1336407(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK1336407T3 publication Critical patent/DK1336407T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
DK01982846T 2000-11-21 2001-11-19 Præparat indeholdende en angiotensin-II-receptorantagonist og et diuretikum og anvendelse deraf til behandling af hypertension DK1336407T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000354327 2000-11-21
JP2001164009 2001-05-31

Publications (1)

Publication Number Publication Date
DK1336407T3 true DK1336407T3 (da) 2006-09-04

Family

ID=26604360

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01982846T DK1336407T3 (da) 2000-11-21 2001-11-19 Præparat indeholdende en angiotensin-II-receptorantagonist og et diuretikum og anvendelse deraf til behandling af hypertension

Country Status (23)

Country Link
US (2) US6878703B2 (da)
EP (2) EP1595540A1 (da)
KR (1) KR100656716B1 (da)
CN (1) CN1265788C (da)
AT (1) ATE324890T1 (da)
AU (2) AU1432402A (da)
BR (1) BR0115516A (da)
CA (1) CA2429260A1 (da)
CY (1) CY1106134T1 (da)
CZ (1) CZ20031367A3 (da)
DE (1) DE60119368T2 (da)
DK (1) DK1336407T3 (da)
ES (1) ES2262689T3 (da)
HU (1) HUP0400553A3 (da)
IL (2) IL155965A0 (da)
MX (1) MXPA03004463A (da)
NO (1) NO332938B1 (da)
NZ (1) NZ525913A (da)
PL (1) PL207252B1 (da)
PT (1) PT1336407E (da)
SK (1) SK5992003A3 (da)
TW (1) TWI262076B (da)
WO (1) WO2002041890A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004208615C1 (en) * 2003-01-31 2010-05-13 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
EP1668008A4 (en) 2003-08-28 2009-02-25 Nitromed Inc NITROSED AND NITROSYLATED DIETETIC COMPOUNDS, COMPOSITIONS AND APPLICATION METHODS
JP4437141B2 (ja) * 2004-09-02 2010-03-24 テバ ファーマシューティカル インダストリーズ リミティド オルメサルタンメドキソミルの精製法
CN1993355A (zh) * 2004-09-02 2007-07-04 特瓦制药工业有限公司 奥美沙坦酯的纯化方法
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CA2597460A1 (en) 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
KR101318032B1 (ko) * 2005-05-20 2013-10-14 다이이찌 산쿄 가부시키가이샤 필름 코팅 제제
TWI367756B (en) * 2005-05-20 2012-07-11 Sankyo Co A film-coated drug product comprising dextrose
WO2007047838A2 (en) * 2005-10-20 2007-04-26 Dr. Reddy's Laboratories Ltd. Process for preparing olmesartan medoxomil
US8077769B2 (en) * 2006-03-28 2011-12-13 Sony Corporation Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach
SI1891952T1 (sl) * 2006-05-04 2012-02-29 Lek Pharmaceuticals, D.D. Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
JP2010508266A (ja) * 2006-10-30 2010-03-18 ハナル ファーマシューティカル カンパニー リミテッド チアジド系化合物およびアンジオテンシン−ｉｉ−受容体遮断剤を含む放出性が制御された薬学的組成物
WO2009113420A1 (ja) 2008-03-13 2009-09-17 第一三共株式会社 オルメサルタンメドキソミルを含む製剤の溶出性の改善
US20100008956A1 (en) * 2008-07-08 2010-01-14 Jie Du Composition and combinations of carboxylic acid losartan in dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
WO2010075347A2 (en) 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
CA3103599A1 (en) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for treatment of hypertension with an angiotensin ii receptor blocker pharmaceutical composition

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3009911A (en) 1961-11-21 Derivatives of j
US2783241A (en) 1957-02-26 S-acylimino-x-substituted-az-i
US3108097A (en) * 1963-10-22 Ehnojs
US3025292A (en) * 1962-03-13 Reduction of i
US3254076A (en) 1966-05-31 Sulfamyl hydro
US2976289A (en) 1961-03-21 X-tetrahydro -
US2554816A (en) 1950-04-04 1951-05-29 American Cyanamid Co Heterocyclic sulfonamides and methods of preparation thereof
GB795174A (en) 1954-10-13 1958-05-21 Upjohn Co Heterocyclic sulphonamides
US2835702A (en) 1956-05-02 1958-05-20 Merck & Co Inc Benzene 1, 3 disulfonamides possessing diuretic properties
US2980679A (en) 1957-04-04 1961-04-18 Omikron Gagliardi Societa Di F Process for preparing heterocyclic sulfonamides
US3055904A (en) 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
GB851287A (en) 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
GB979994A (en) * 1961-07-28 1965-01-06 May & Baker Ltd Isoindolinone derivatives
US3265573A (en) 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
BE639386A (da) * 1962-10-30
DE1278443C2 (de) 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
US3163645A (en) 1964-09-25 1964-12-29 Ciba Geigy Corp Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides
DE1270544B (de) * 1965-06-19 1968-06-20 Beiersdorf Ag 4-Chlor-5-sulfamylsalicylsaeure-(2', 6'-dimethyl)-anilid und dessen Alkali- oder Ammonium-Salze sowie Verfahren zu deren Herstellung
US3360518A (en) * 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
US3634583A (en) * 1969-07-24 1972-01-11 Leo Pharm Prod Ltd Pharmaceutical composition for the treatment of oedematous conditions and hypertension
BE757001A (fr) 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0733366B1 (en) * 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
US5656650A (en) * 1990-12-14 1997-08-12 Smithkline Beecham Corp. Angiotensin II receptor blocking compositions
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist

Also Published As

Publication number Publication date
CN1486182A (zh) 2004-03-31
US6878703B2 (en) 2005-04-12
DE60119368D1 (de) 2006-06-08
DE60119368T2 (de) 2007-05-03
NO20032261L (no) 2003-07-09
NZ525913A (en) 2004-05-28
EP1336407B1 (en) 2006-05-03
EP1336407A4 (en) 2004-07-14
IL155965A (en) 2008-08-07
ES2262689T3 (es) 2006-12-01
NO332938B1 (no) 2013-02-04
AU2002214324B2 (en) 2004-07-29
HUP0400553A3 (en) 2010-03-29
WO2002041890A1 (en) 2002-05-30
HUP0400553A2 (hu) 2004-06-28
SK5992003A3 (en) 2003-11-04
NO20032261D0 (no) 2003-05-20
PL207252B1 (pl) 2010-11-30
ATE324890T1 (de) 2006-06-15
PT1336407E (pt) 2006-07-31
KR20030096235A (ko) 2003-12-24
US20040002529A1 (en) 2004-01-01
CY1106134T1 (el) 2011-06-08
EP1595540A1 (en) 2005-11-16
CZ20031367A3 (cs) 2003-10-15
KR100656716B1 (ko) 2006-12-13
CA2429260A1 (en) 2002-05-30
BR0115516A (pt) 2004-02-03
PL361093A1 (en) 2004-09-20
HK1054692A1 (en) 2003-12-12
AU1432402A (en) 2002-06-03
MXPA03004463A (es) 2003-08-19
US20050113367A1 (en) 2005-05-26
CN1265788C (zh) 2006-07-26
EP1336407A1 (en) 2003-08-20
IL155965A0 (en) 2003-12-23
TWI262076B (en) 2006-09-21

Similar Documents

Publication Publication Date Title
DK1336407T3 (da) Præparat indeholdende en angiotensin-II-receptorantagonist og et diuretikum og anvendelse deraf til behandling af hypertension
EA200501075A1 (ru) Лекарственное средство для профилактики и лечения артериосклероза и гипертензии
ATE204873T1 (de) Naphthyridinderivate als angiotensin-ii- antagonist-inhibitoren
DE60023318D1 (de) Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
ATE109481T1 (de) Diazinderivate als angiotensin ii rezeptor antagonisten.
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
DE60322267D1 (de) Chinolinderivate als glucokinase liganden
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
LV12047A (lv) Kondenseti pirimidina atvasinajumi un to lietosana par angiotenzina II antagonistiem
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE453389T1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
ATE402151T1 (de) 2-(arylphenyl)amino-imidazolin-derivate
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
DK1146872T3 (da) Anvendelse af angiotensin II-receptorantagonister til behandling af akut myokardieinfarkt
DK0896822T3 (da) 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister
Olson et al. Balanced angiotensin II receptor antagonists. II. 1, 2 4-aminomethyl-and acylaminomethylimidazoles
DE60239324D1 (de) Phenyl- und pyridyl-piperidine mit tnf-wirkung
SE9902596D0 (sv) Pharmaceutically active compounds
DE60314158D1 (de) Pyrazolderivate als gnrh-inhibitoren